Antidiarrheal Drugs: Mechanisms, Uses, and Contraindications

Opioid-Related Antidiarrheals

Drug example: diphenoxylate/atropine (Lomotil)

MOA of diphenoxylate/atropine

Opioid agonist slows intestinal peristalsis; atropine discourages abuse by causing anticholinergic side effects.

Key use of diphenoxylate/atropine

Acute non-infectious diarrhea (symptomatic control).

Adverse effects of diphenoxylate/atropine

Constipation, Dry mouth, Urinary retention, Tachycardia, Hypotension (dose-related), Respiratory depression (opioid-related, high doses).

Nursing note for diphenoxylate/atropine

Contraindicated in infectious or toxin-mediated diarrhea (e.g., C. difficile). Risk of trapping pathogens/toxins in gut and worsening disease.

Drug example: loperamide

Imodium

MOA of loperamide

Peripheral opioid receptor agonist → decreases intestinal motility and increases water absorption; minimal CNS penetration.

Key use of loperamide

Acute non-infectious diarrhea (OTC first-line).

Adverse effects of loperamide

Constipation, Abdominal cramping, Dizziness (rare), At high doses: opioid-like toxicity.

Nursing note for loperamide

Do NOT use in infectious diarrhea (especially C. difficile or toxin-mediated causes). Requires etiologic assessment before administration.

Antisecretory / Adsorbent Agent

Drug example: bismuth subsalicylate (Pepto-Bismol)

MOA of bismuth subsalicylate

Decreases intestinal secretion, has mild antimicrobial activity, and salicylate component provides anti-inflammatory effects.

Key use of bismuth subsalicylate

Mild diarrhea, traveler's diarrhea, GI upset.

Adverse effects of bismuth subsalicylate

Black tongue, Black stool (harmless), Constipation (mild), Salicylate-related toxicity (rare).

Nursing note for bismuth subsalicylate

Contraindicated in children/teens recovering from viral illness due to risk of Reye syndrome. Warn patients about harmless stool discoloration.

Somatostatin Analog

Drug example: octreotide (Sandostatin)

MOA of octreotide

Synthetic somatostatin analog → inhibits GI hormone secretion and reduces intestinal motility.

Key use of octreotide

Severe secretory diarrhea (refractory cases, e.g., endocrine or high-output diarrhea).

Adverse effects of octreotide

Abdominal pain, Nausea, Gallstones (long-term use), Steatorrhea.

Nursing note for octreotide

Reserved for severe or refractory diarrhea. Monitor glucose and GI function due to broad inhibitory effects on GI hormones.

Absolute contraindication rule

Do NOT slow the gut if cause is infectious/toxin-mediated (e.g., C. difficile, Food poisoning/toxin exposure).

Core mechanism logic

Drug class effect on gut: Loperamide/diphenoxylate ↓ peristalsis; Bismuth subsalicylate ↓ secretion + mild antimicrobial; Octreotide ↓ secretion + ↓ motility (hormonal suppression).

Nursing priority hierarchy

Fluid + electrolyte replacement (NON-NEGOTIABLE), Identify cause (infectious vs non-infectious), Decide if antidiarrheal is safe, Monitor complications (esp. potassium loss → arrhythmia risk).

Key complication pattern

Hypokalemia → cardiac dysrhythmias; Dehydration → hypotension, tachycardia, poor perfusion.